MSB 3.13% 99.0¢ mesoblast limited

MSB Trading 2021 - paradigm shift, page-7745

  1. 12,457 Posts.
    lightbulb Created with Sketch. 3377
    @Kydog - good for you that you sold out and feel good about it.
    Everyone got a different level of tolerance. That's ok - NP.

    Just to be clear though, I'm not profiting or even trying to profit from any other SHs.
    I haven't sold a single share in MSB.
    Could I have done better by trading - of course I could have.
    But, heck - that's being a hindsight expert!

    I'm simply sharing my thoughts on a stock that I own - and fancy that I'm bias towards my investment.

    Yes, it is a long journey and we've been bruised and beaten up by the falling SP.
    But, my positivity is genuine as that's how I'm wired.

    If I thought that I'm holding on to false hope, I would have sold too.
    However, I'm a strong believer of the science and SI - in delivering a paradigm shift in medical treatment.
    SI has the most to lose and he hasn't sold out - has he?

    Timing is everything and I believe atm the market has mis-priced MSB and it's only a matter of time before the SP will improve.
    I don't think I'm the only MSB SH with this mindset eek.png
    And you would find many SHs on other stocks with the same mindset. How dare they hold on to their stock with a falling SP?

    It's called having an investment thesis and investing with conviction - it not an easy thing to do, it's frustrating - but, I'm holding!

    BTW @chuckle - yes, we need some +ve catalysts for a decent 'upwards' part of my sign-off
    Last edited by ddwn: 17/09/21
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
99.0¢
Change
0.030(3.13%)
Mkt cap ! $1.130B
Open High Low Value Volume
96.5¢ $1.03 96.5¢ $4.704M 4.708M

Buyers (Bids)

No. Vol. Price($)
6 87395 98.5¢
 

Sellers (Offers)

Price($) Vol. No.
$1.00 274051 2
View Market Depth
Last trade - 16.10pm 14/08/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.